These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2870577)

  • 1. Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma.
    de Jong WH; Teppema JS; Wagenaar SS; Paques M; Steerenberg PA; Ruitenberg EJ
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 50(3):249-69. PubMed ID: 2870577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P; Mathews HL
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig.
    Steerenberg PA; De Jong WH; Geerse E; Beuvink A; Scheper RJ; Den Otter W; Ruitenberg EJ
    Cancer Immunol Immunother; 1990; 31(5):297-304. PubMed ID: 2376047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
    Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P
    Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; Steerenberg PA; van de Plas MM; Kruizinga W; Ruitenberg J
    J Natl Cancer Inst; 1985 Sep; 75(3):483-9. PubMed ID: 3875751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of immunologic eradication of a syngeneic guinea pig tumor. I. Quantitative analysis of adoptive immunity.
    Shu S; Hunter JT; Rapp HJ; Fonseca LS
    J Natl Cancer Inst; 1982 Apr; 68(4):673-80. PubMed ID: 6951081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
    Smith HG; Bast RC; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates.
    Dvorak HF; Dvorak AM; Churchill WH
    J Exp Med; 1973 Mar; 137(3):751-75. PubMed ID: 4347597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional administration of etoposide, but not of interleukin 2, facilitates active specific immunization in guinea pigs with advanced carcinoma.
    Claessen AM; Bloemena E; Bril H; Meijer CJ; Scheper RJ
    Cancer Res; 1992 May; 52(9):2440-6. PubMed ID: 1568214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of microscopic hepatic metastases by active specific immunization.
    Sukumar S; Hunter JT; Terata N; Rapp HJ
    Cancer Immunol Immunother; 1983; 14(3):151-4. PubMed ID: 6340824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of immunological eradication of a syngeneic guinea pig tumor. II. Effect of methotrexate treatment and T cell depletion of the recipient on adoptive immunity.
    Shu S; Fonseca LS; Hunter JT; Rapp HJ
    Transplantation; 1983 Jan; 35(1):56-61. PubMed ID: 6297130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour rejection in immunized guinea-pigs.
    Kolin A; Vacek J; Landi S
    Br J Exp Pathol; 1983 Oct; 64(5):542-7. PubMed ID: 6639873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activity.
    Balemans LT; Mattijssen V; Steerenberg PA; Van Driel BE; De Mulder PH; Den Otter W
    Cancer Immunol Immunother; 1993 Jul; 37(1):7-14. PubMed ID: 8513455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
    Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific tumor memory induced by polyethylene-glycol-modified interleukin-2 requires both helper and cytotoxic T cells.
    Balemans LT; Steerenberg PA; Kremer BH; Koppenhagen FJ; De Mulder PH; Den Otter W
    Cancer Immunol Immunother; 1995 Feb; 40(2):125-31. PubMed ID: 7882383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.